# Kingstone Companies, Inc.: financial statements, quarterly

KINS · Nasdaq · CIK 33992 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kins.md) · [Financials](/companies/kins/financials.md) · [Filings](/companies/kins/filings.md) · [Insiders](/companies/kins/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kins/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [34.2](/filings/0001628280-24-047833.md) | [36.6 d](/filings/0000033992-25-000007.md) | [35.8](/filings/0000033992-25-000017.md) | [36.5](/filings/0000033992-25-000020.md) | [40.8](/filings/0000033992-25-000027.md) | [42.1 d](/filings/0000033992-26-000013.md) | [50.5](/filings/0000033992-26-000020.md) | [52.3](/filings/0000033992-26-000037.md) | [55.7](/filings/0000033992-25-000027.md) | [56.4 d](/filings/0000033992-26-000013.md) | [59.8](/filings/0000033992-26-000020.md) | [65.9](/filings/0000033992-26-000037.md) |
| Interest expense | $m | [1.0](/filings/0001654954-23-014618.md) | [1.0 d](/filings/0001654954-24-004054.md) | [1.0](/filings/0001654954-24-006368.md) | [1.0](/filings/0001654954-24-010605.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(0.9)](/filings/0001628280-24-047833.md) | [1.0 d](/filings/0000033992-25-000007.md) | [0.4](/filings/0000033992-25-000017.md) | [1.2](/filings/0000033992-25-000020.md) | [2.1](/filings/0000033992-25-000027.md) | [1.2 d](/filings/0000033992-26-000013.md) | [0.8](/filings/0000033992-26-000020.md) | [2.9](/filings/0000033992-26-000037.md) | [2.8](/filings/0000033992-25-000027.md) | [3.7 d](/filings/0000033992-26-000013.md) | [(1.6)](/filings/0000033992-26-000020.md) | [4.0](/filings/0000033992-26-000037.md) |
| Net income | $m | [(3.5)](/filings/0001628280-24-047833.md) | [2.9 d](/filings/0000033992-25-000007.md) | [1.4](/filings/0000033992-25-000017.md) | [4.5](/filings/0000033992-25-000020.md) | [7.0](/filings/0000033992-25-000027.md) | [5.4 d](/filings/0000033992-26-000013.md) | [3.9](/filings/0000033992-26-000020.md) | [11.3](/filings/0000033992-26-000037.md) | [10.9](/filings/0000033992-25-000027.md) | [14.8 d](/filings/0000033992-26-000013.md) | [(5.8)](/filings/0000033992-26-000020.md) | [15.5](/filings/0000033992-26-000037.md) |
| Diluted EPS | $ per share | [(0.33)](/filings/0001628280-24-047833.md) | not reported | [0.12](/filings/0000033992-25-000017.md) | [0.37](/filings/0000033992-25-000020.md) | [0.55](/filings/0000033992-25-000027.md) | not reported | [0.27](/filings/0000033992-26-000020.md) | [0.78](/filings/0000033992-26-000037.md) | [0.74](/filings/0000033992-25-000027.md) | not reported | [(0.40)](/filings/0000033992-26-000020.md) | [1.05](/filings/0000033992-26-000037.md) |
| Basic EPS | $ per share | [(0.33)](/filings/0001628280-24-047833.md) | not reported | [0.13](/filings/0000033992-25-000017.md) | [0.41](/filings/0000033992-25-000020.md) | [0.61](/filings/0000033992-25-000027.md) | not reported | [0.29](/filings/0000033992-26-000020.md) | [0.81](/filings/0000033992-26-000037.md) | [0.77](/filings/0000033992-25-000027.md) | not reported | [(0.40)](/filings/0000033992-26-000020.md) | [1.07](/filings/0000033992-26-000037.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [15.1](/filings/0001654954-23-014618.md) | [9.0](/filings/0001654954-24-004054.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [317](/filings/0001654954-23-014618.md) | [318](/filings/0000033992-25-000007.md) | [318](/filings/0001654954-24-006368.md) | [320](/filings/0001654954-24-010605.md) | [347](/filings/0001628280-24-047833.md) | [375](/filings/0000033992-26-000013.md) | [385](/filings/0000033992-25-000017.md) | [393](/filings/0000033992-25-000020.md) | [429](/filings/0000033992-25-000027.md) | [453](/filings/0000033992-26-000037.md) | [465](/filings/0000033992-26-000020.md) | [478](/filings/0000033992-26-000037.md) |
| Total liabilities | $m | [290](/filings/0001654954-23-014618.md) | [283](/filings/0000033992-25-000007.md) | [283](/filings/0001654954-24-006368.md) | [279](/filings/0001654954-24-010605.md) | [287](/filings/0001628280-24-047833.md) | [308](/filings/0000033992-26-000013.md) | [303](/filings/0000033992-25-000017.md) | [299](/filings/0000033992-25-000020.md) | [321](/filings/0000033992-25-000027.md) | [331](/filings/0000033992-26-000037.md) | [351](/filings/0000033992-26-000020.md) | [349](/filings/0000033992-26-000037.md) |
| Long-term debt | $m | [25.2](/filings/0001654954-23-014618.md) | [5.7](/filings/0000033992-25-000007.md) | [25.3](/filings/0001654954-24-006368.md) | [25.3](/filings/0001654954-24-010605.md) | [16.4](/filings/0001628280-24-047833.md) | [4.3](/filings/0000033992-26-000013.md) | [4.1](/filings/0000033992-25-000017.md) | [3.8](/filings/0000033992-25-000020.md) | [3.5](/filings/0000033992-25-000027.md) | [3.1](/filings/0000033992-26-000037.md) | [2.8](/filings/0000033992-26-000020.md) | [2.5](/filings/0000033992-26-000037.md) |
| Current portion of debt | $m | [25.2](/filings/0001654954-23-014618.md) | [19.6](/filings/0000033992-25-000007.md) | [25.3](/filings/0001654954-24-006368.md) | [25.3](/filings/0001654954-24-010605.md) | [0.9](/filings/0001628280-24-047833.md) | [6.8](/filings/0000033992-26-000013.md) | [1.2](/filings/0000033992-25-000017.md) | [1.3](/filings/0000033992-25-000020.md) | [1.3](/filings/0000033992-25-000027.md) | [1.3](/filings/0000033992-26-000037.md) | [1.3](/filings/0000033992-26-000020.md) | [1.3](/filings/0000033992-26-000037.md) |
| Shareholders' equity | $m | [26.5](/filings/0001628280-24-047833.md) | [34.5](/filings/0000033992-26-000013.md) | [35.7](/filings/0000033992-25-000020.md) | [40.8](/filings/0000033992-25-000027.md) | [59.7](/filings/0000033992-25-000027.md) | [66.7](/filings/0000033992-26-000037.md) | [82.2](/filings/0000033992-26-000037.md) | [94.9](/filings/0000033992-26-000037.md) | [108](/filings/0000033992-25-000027.md) | [123](/filings/0000033992-26-000037.md) | [115](/filings/0000033992-26-000037.md) | [129](/filings/0000033992-26-000037.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent, us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1.3 d](/filings/0001628280-24-047833.md) | [4.4 d](/filings/0000033992-25-000007.md) | [6.1](/filings/0000033992-25-000017.md) | [7.1 d](/filings/0000033992-25-000020.md) | [21.7 d](/filings/0000033992-25-000027.md) | [23.0 d](/filings/0000033992-26-000013.md) | [17.9](/filings/0000033992-26-000020.md) | [9.3 d](/filings/0000033992-26-000037.md) | [25.9 d](/filings/0000033992-25-000027.md) | [22.8 d](/filings/0000033992-26-000013.md) | [8.7](/filings/0000033992-26-000020.md) | [28.7 d](/filings/0000033992-26-000037.md) |
| Capital expenditure | $m | [0.5 d](/filings/0001628280-24-047833.md) | [0.4 d](/filings/0000033992-25-000007.md) | [0.5](/filings/0000033992-25-000017.md) | [0.5 d](/filings/0000033992-25-000020.md) | [0.7 d](/filings/0000033992-25-000027.md) | [0.6 d](/filings/0000033992-26-000013.md) | [0.9](/filings/0000033992-26-000020.md) | [0.6 d](/filings/0000033992-26-000037.md) | [0.7 d](/filings/0000033992-25-000027.md) | [0.7 d](/filings/0000033992-26-000013.md) | [0.8](/filings/0000033992-26-000020.md) | [0.9 d](/filings/0000033992-26-000037.md) |
| Dividends paid | $m | [0.0 d](/filings/0001654954-23-014618.md) | [0.0 d](/filings/0001654954-24-004054.md) | not reported | not reported | not reported | [0.0 d](/filings/0000033992-26-000013.md) | [0.0](/filings/0000033992-26-000020.md) | [0.0 d](/filings/0000033992-26-000037.md) | [0.7 d](/filings/0000033992-25-000027.md) | [0.7 d](/filings/0000033992-26-000013.md) | [0.7](/filings/0000033992-26-000020.md) | [0.7 d](/filings/0000033992-26-000037.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.6](/filings/0001654954-23-014618.md) | [10.8](/filings/0001654954-24-006368.md) | [10.8](/filings/0001654954-24-010605.md) | [10.8](/filings/0001628280-24-047833.md) | [11.8](/filings/0000033992-25-000017.md) | [12.1](/filings/0000033992-25-000020.md) | [12.6](/filings/0000033992-25-000027.md) | [14.3](/filings/0000033992-26-000020.md) | [14.4](/filings/0000033992-26-000037.md) | [14.6](/filings/0000033992-25-000027.md) | [14.5](/filings/0000033992-26-000020.md) | [14.7](/filings/0000033992-26-000037.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 14,476,133 at 2026-08-04, from the cover of the [10-Q filed 2026-08-07](/filings/0000033992-26-000037.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.